[1] The Joint United Nations Program on HIV/AIDS. Global HIV & AIDS statistics — 2018 fact sheet. UNAIDS, 2018. Available at: https://www.unaids.org/en/resources/fact-sheet. [2019-7-15]
[2] Ma Y, Dou Z, Guo W, et al. The human immunodeficiency virus care continuum in China: 1985−2015. Clin Infect Dis, 2018; 66, 833−9. doi:  10.1093/cid/cix911
[3] Zhao Y, McGoogan JM, Wu Z. The benefits of immediate ART. J Int Assoc Provid AIDS Care, 2019; 18, 2325958219831714.
[4] Fatti G, Grimwood A, Nachega JB, et al. Better virological outcomes amongst people living with HIV initiating early antiretroviral treatment (CD4 counts ≥ 500 cells/µL) in the HPTN 071 (PopART) trial in south Africa. Clin Infect Dis, 2019; ciz214. doi:  10.1093/cid/ciz214
[5] Tang Z, Pan SW, Ruan Y, et al. Effects of high CD4 cell counts on death and attrition among HIV patients receiving antiretroviral treatment: an observational cohort study. Sci Rep, 2017; 7, 3129. doi:  10.1038/s41598-017-03384-7
[6] Boyd MA, Boffito M, Castagna A, et al. Rapid initiation of antiretroviral therapy at HIV diagnosis: definition, process, knowledge gaps. HIV Med, 2019; 20(Suppl 1), 3−11.
[7] Chinese Medical Association, Chinese Center for Disease Control and Prevention. Guidelines for diagnosis and treatment of HIV/AIDS in China (2018). Chin J AIDS STD, 2018; 24, 1266−82.
[8] Mangal TD, Meireles MV, Pascom ARP, et al. Determinants of survival of people living with HIV/AIDS on antiretroviral therapy in Brazil 2006–2015. BMC Infect Dis, 2019; 19, 206. doi:  10.1186/s12879-019-3844-3
[9] Zhao Y, Wu Z, McGoogan JM, et al. Immediate antiretroviral therapy decreases mortality among patients with high CD4 counts in China: a nationwide, retrospective cohort study. Clin Infect Dis, 2018; 66, 727−34. doi:  10.1093/cid/cix878
[10] Tang H, Mao Y, Tang W, et al. 'Late for testing, early for antiretroviral therapy, less likely to die': results from a large HIV cohort study in China, 2006-2014. BMC Infect Dis, 2018; 18, 272. doi:  10.1186/s12879-018-3158-x